LH
Labcorp Holdings Inc. · Healthcare · Medical - Diagnostics & Research
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham -0.9% · posisi baru bersih -5.3% · formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 88.13K | $17.42M | n/a | n/a |
| Q2 2026 | 156 | +5 | 55.88M | $15.63B | +9 | −5 |
| Q1 2026 | 155 | +1 | 55.32M | $14.74B | +4 | −4 |
| Q4 2025 | 153 | -1 | 61.82M | $15.50B | +1 | −1 |
| Q3 2025 | 19 | 0 | 33.10M | $9.50B | n/a | −1 |
| Q2 2025 | 17 | -1 | 30.31M | $7.95B | +1 | −2 |
| Q1 2025 | 15 | +2 | 7.94M | $1.85B | +2 | n/a |
| Q4 2024 | 13 | 0 | 9.58M | $2.20B | +2 | −2 |
| Q3 2024 | 12 | +1 | 4.32M | $962.67M | +2 | −1 |
| Q2 2024 | 11 | n/a | 5.93M | $1.21B | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasif) | 9.81M | -0.7% | $2.82B | 0.0% | ▼ Trim | 2 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (pasif) | 8.13M | -10.3% | $2.33B | 0.0% | ▼ Trim | 2 | SEC ↗ ×20 |
| 3 | State Street Global Advisors ✦ (pasif) | 3.83M | -0.8% | $1.10B | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | JPMorgan Chase ✦ | 2.15M | n/a | $616.63M | 0.0% | n/c | 1 | SEC ↗ ×30 |
| 5 | Geode Capital Management ✦ (pasif) | 2.12M | +0.5% | $606.94M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | Wellington Management ✦ | 2.11M | +15.9% | $604.49M | 0.1% | ▲ Add | 6 | SEC ↗ ×8 |
| 7 | Morgan Stanley ✦ | 1.51M | n/a | $432.71M | 0.0% | n/c | 1 | SEC ↗ ×17 |
| 8 | Fidelity (FMR) ✦ | 1.45M | -13.5% | $415.73M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 9 | Marshall Wace ✦ | 623.55K | +79.1% | $179.00M | 0.2% | ▲ Add | 3 | SEC ↗ ×3 |
| 10 | Citadel Advisors ✦ | 516.55K | +268.3% | $148.28M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 11 | Goldman Sachs Group ✦ | 422.15K | n/a | $121.18M | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 12 | AQR Capital Management ✦ | 163.33K | +4.2% | $46.42M | 0.0% | ▲ Add | 6 | SEC ↗ ×5 |
| 13 | T. Rowe Price ✦ | 120.19K | -0.3% | $34.50M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 14 | Gotham Asset Management ✦ | 95.03K | +39.2% | $27.28M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 15 | Adage Capital Partners ✦ | 23.70K | 0.0% | $6.80M | 0.0% | Held | 4 | SEC ↗ |
| 16 | Millennium Management ✦ | 10.70K | -35.5% | $3.07M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 10.39K | +275.1% | $2.98M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 18 | Arrowstreet Capital ✦ | 5.31K | -76.3% | $1.52M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Fisher Asset Management ✦ | 1.73K | +4.2% | $496,671 | 0.0% | ▲ Add | 6 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Norges Bank | $263.07M | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1,014 pemegang, 76.41M saham, $19.36B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Director · 3.00K lbr · $954,060
Officer, Director · 4.67K lbr · $1.50M
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi